Elvira B. Prohorova

Elvira B. Prohorova

Auto-generated profile, based on publicly available information

Elvira B. Prohorova

State Organization «Grigoriev Institute for Medical Radiology and Oncology of the National Academy of Medical Sciences of Ukraine», Kharkiv, Ukraine

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2023 in Український радіологічний та онкологічний журнал
Verified
Journal Article
Open access
PDF file
МКМ.в. Красносельський
М.в. Красносельський
ВСВ.п. Старенький
В.п. Старенький
NAN.O. Artamonova
N.O. Artamonova
HKH.V. Kulinich
H.V. Kulinich
EPE.B. Prokhorova
E.B. Prokhorova
MHM.V. Havrylenko
M.V. Havrylenko
Background. The World Health Organization (WHO) has confirmed the outbreak of covid infection and defined it as a global pandemic. Recently, complications have been increasingly reported in patients who have had COVID-19. At the same time, clinical symptoms of the long-term course of this disease overlap, differing from acute manifestations of the infection, and may persist in recovered patients for several weeks, months or years, adding a number of other problems. Therefore, the importance of a thorough study of the post-COVID-19 syndrome as a modern phenomenon has increased. And this syndrome requires proper research to improve the efficiency of its prevention and treatment. Purpose. To evaluate the current state of the problem of post-COVID-19 syndrome, in particular in cancer patients. Materials and methods. A literature review was performed based on the array of digital publications found in the world databases PubMed, Scopus and Web of Science Core Collection for 2020–2023. The sources were systematized in separate groups, i.e., issues related to post-Covid, in particular, the mechanisms and pathogenesis of its development; treatment features, including cancer patients; long-term consequences in recovered patients, etc. Results and discussion. The terminology on the subject of the study has been analyzed: post-COVID, post-COVID syndrome, PASC, long-COVID, acute COVID, chronic COVID, etc. The views regarding the pathogenesis of post-COVID syndrome and its main symptoms were systematized. It is determined that in the field of oncology, research is conducted in certain fields and the risk of progression and occurrence of cancer in the post-COVID period is evaluated; the efficiency of the process of cancer care organization in the post-COVID period and the level of complications and mortality of cancer patients who have suffered from COVID-19. The pandemic has also led to multiple changes in the field of radiological diagnosis of the consequences of cancer patients with COVID. Evaluating the impact of the pandemic on the outcomes and adaptation of radiotherapy and chemotherapy, it was determined that delays in the provision of timely care and changes in treatment regimens will affect long-term survival of cancer patients. Conclusion. Assessing the current state of the problem of post-COVID syndrome, most researchers believe that cancer progression during delay in cancer care will negatively affect the long-term survival of cancer patients, and coincidence of cancer-related symptoms and symptoms of long-term COVID is another major challenge for oncologists in the future. Актуальність. Всесвітня організація охорони здоров’я (ВООЗ) підтвердила спалах ковідної інфекції і визначила її як глобальну пандемію. Останнім часом у пацієнтів, які перехворіли на COVID-19, дедалі частіше відмічаються ускладнення, при цьому клінічні симптоми тривалого перебігу цього захворювання перекриваються, відрізняючись від гострих проявів інфекції, і можуть зберігатися в пацієнтів, які одужали, впродовж кількох тижнів, місяців або років, додаючи масу інших проблем. Саме тому зросла актуальність питань досконалого вивчення пост-COVID-19-синдрому як феномену сучасності, який потребує свого пізнання для підвищення ефективності його профілактики та лікування. Мета роботи. Оцінити сучасний стан проблеми пост-COVID-19-синдрому, зокрема в онкологічних хворих. Матеріали та методи. Проведено огляд літератури, який базується на масиві цифрових публікацій, що знайдено у світових ресурсах PubMed, Scopus та Web of Science Core Collection за 2020–2023 рр. Систематизацію джерел проводили за окремими напрямками, тобто з питань стосовно пост-Covid, зокрема механізмів та патогенезу його розвитку; особливостей лікування, у тому числі онкологічних хворих; віддалених наслідків у пацієнтів, які перехворіли та ін. Результати та їх обговорення. Проаналізовано термінологію за предметом дослідження «постковід» (post-COVID), «постковідний синдром» (post-COVID syndrome, PASC), «тривалий COVID» (long-COVID), «гострий COVID» (acute COVID), «хронічний COVID» (chronic COVID) та ін. Проведено систематизацію поглядів на патогенез постковідного синдрому та його головні симптоми. Визначено, що у сфері онкології дослідження проводять у деяких напрямках та оцінюють ризик прогресування та виникнення онкологічних захворювань у постковідний термін; ефективність процесу організації онкологічної допомоги у постковідний період та рівень ускладнень та смертності онкологічних пацієнтів, які перехворіли на COVID-19....

30 March 2023 in Український радіологічний та онкологічний журнал
Verified
Journal Article
Open access
PDF file
ODO.E. Dubenko
O.E. Dubenko
HKH.V. Kulinich
H.V. Kulinich
EPE.B. Prokhorova
E.B. Prokhorova
TKT.V. Kulchaeva
T.V. Kulchaeva
SDS.V. Danyliuk
S.V. Danyliuk
Background. Metastases to the brain (brain metastases (BM)) are the most common intracranial tumors in adults and occur 3–10 times more frequently than primary brain tumors. In 15% of patients with BM, the primary tumor cannot be determined, which is known as BM cancer of unknown primary. Cancer of unknown primary is the seventh/eighth common malignancy and the fourth leading cause of cancer-related death, often characterized by early and aggressive metastatic spread, poor response to chemotherapy, and poor prognosis. Purpose – To study the course of brain metastases in cancer of unknown primary on the example of clinical cases. Materials and methods. Clinical observation of male patient N., 50 years old, who was diagnosed with a metachronous disease with metastatic damage to the lymph nodes, the excisional biopsy of which established a metastasis of squamous non-keratinous carcinoma and a solitary voluminous neoplasm of the brain, which during the initial examination was considered as IV glioma. Clinical observation of patient B., 40 years old, in whom the primary manifestation of the disease was a solitary neoplasm of the brain, the pathohistological examination of which was regarded as a metastasis of grade III small cell neuroendocrine carcinoma, but the localization of the primary cancer was not established. The examination and treatment were performed in the State Organization «Grigoriev Institute for Medical Radiology and Oncology of the National Academy of Medical Sciences of Ukraine». Results. The clinical cases of BM cancer of unknown primary in two patients aged 50 and 40 years old, which according to histopathological examination were probably low-differentiated squamous cell adenocarcinoma, are presented. The difficulties of diagnostic search for primary cancer and treatment of such patients are shown. Conclusion. Brain metastases cancer of unknown primary, as well as the differential diagnosis of primary brain gliomas and solitary metastases, remain a complex diagnostic and therapeutic medical problem that is a challenge for oncologists, neurosurgeons and neurologists alike. Further study of this problem is necessary for the effective treatment of such patients. Актуальність. Метастази в головний мозок – мозкові метастази (ММ), є найпоширенішими внутрішньочерепними пухлинами у дорослих і виникають у 3–10 разів частіше, ніж первинні пухлини головного мозку. У 15% пацієнтів із ММ первинну пухлину неможливо визначити, це так звані МM невідомого первинного раку. Невідомий первинний рак займає сьоме/восьме місце серед поширених злоякісних пухлин і є четвертою за поширеністю причиною смерті, пов’язаною з раком, часто характеризується раннім та агресивним метастатичним поширенням, поганою відповіддю на хіміотерапію та невтішний прогноз. Мета роботи. Дослідити на прикладі клінічних випадків перебіг мозкових метастазів при невідомому первинному раку. Матеріали та методи дослідження. Клінічне спостереження пацієнта Н., 50 років, у якого діагностовано метахронне захворювання з метастатичним ураженням лімфовузлів, ексцизійна біопсія яких встановила метастаз плоскоклітинної незроговілої карциноми та солітарне об’ємне новоутворення головного мозку, що при первинному дослідженні було розцінене як гліома IV. Клінічне спостереження пацієнта Б., 40 років, у якого первинним проявом захворювання було солітарне новоутворення головного мозку, патогістологічне дослідження якого було розцінене як метастаз дрібноклітинної нейроендокринної карциноми ІІІ градації, але локалізація первинного раку встановлена не була. Обстеження та лікування проводилось в умовах Державної установи «Інститут медичної радіології та онкології ім. С.П. Григор’єва Національної академії медичних наук України». Результати та їх обговорення. Представлено клінічні випадки мозкових метастазів невідомого первинного раку у двох пацієнтів 50 и 40 років, який за даними патогістологічного дослідження був, ймовірно, низькодиференційованою плоскоклітинною аденокарциномою. Показані труднощі діагностичного пошуку первинного раку та лікування таких пацієнтів. Висновки. Мозкові метастази невідомого первинного раку, також і як диференціальна діагностика первинних гліом головного мозку і солітарних метастазів, залишаються...

17 December 2020 in Український радіологічний та онкологічний журнал
Verified
Journal Article
Open access
PDF file
HKH. V. Kulinich
H. V. Kulinich
RSR. M. Spuziak
R. M. Spuziak
ANA. M. Nasonova
A. M. Nasonova
LCL. V. Cherkasko
L. V. Cherkasko
MMM. V. Moskalenko
M. V. Moskalenko
ЕОЕ. Б. Орловська
Е. Б. Орловська
Background. The outbreak of the new coronavirus disease in 2019 (COVID19) has been the largest global health threat in the world, that infected more than 60 million people and killed more than 1,400,000. At the same time, cancer remains a widespread disease, from which more than 9.6 million patients in the world die each year. Accumulating data suggest that cancer patients are at higher risk of infection COVID-19 and severe course of the disease. This is due to immunosuppression, which is due to both the malignant tumor and antitumor therapy. Clinical manifestations of lung damage in cancer patients are not pathognomonic, because they can be caused by any pathological processes: metastatic lesions, inflammatory processes of viral and bacterial etiology, vascular disorders in the small circulation, etc. This requires not only to determine the nature of pathological changes in the lungs, but also to carry out their differential diagnosis in order to prescribe timely and adequate therapy. Purpose – elucidation of the relevance of X-ray diagnosis of pneumonia in cancer patients during the COVID-19 pandemic. Materials and methods. Follow-up of a patient K., 72 years old, who had coronavirus pneumonia along with complications (febrile neutropenia) resulting from chemoteraphy of recurrent endometrial leiomyosarcoma. The treatment was provided on the premises of Clinical Oncology and Hematology Department of State Organization «Grigoriev Institute for Medical Radiology and Oncology of the National Academy of Medical Sciences of Ukraine». Results and discussion. Over a period of 6 month, the patient was undergoing polychemotherapy (with complications like febrile neutropenia) of recurrent endometrial leiomyosarcoma. The control CT study detected pulmonary involvement. After receiving laboratory confirmation of COVID-19, was treated in the infectious department. The course of the disease was severe. Analyzing this clinical case of a patient with cancer in the process of special treatment, it is impossible to exclude the presence of progression in the lungs or drug pulmonitis. A favorable treatment result (negative PCR test, positive dynamics on CT) proves the non-metastatic nature of lung damage. Conclusions.. Diagnosis of COVID-19 infection should be based on the integrated application of clinical, radiological and laboratory research methods. Chest computed tomography, taking into account its high sensitivity, helps in diagnosis, control of the disease, playing an important role in the differential diagnosis and treatment tactics of COVID-19.

30 June 2022 in Український радіологічний та онкологічний журнал
Verified
Journal Article
Open access
PDF file
HKH.V. Kulinich
H.V. Kulinich
EPE.B. Prokhorova
E.B. Prokhorova
MMM.V. Moskalenko
M.V. Moskalenko
ANA.M. Nasonova
A.M. Nasonova
SDS.V. Danyliuk
S.V. Danyliuk
ГКГ.в. Кулініч
Г.в. Кулініч
Background. Basal cell carcinoma (BCC) occupies around 80% of all the cases of diagnosed skin cancer (according to American Cancer Society). In various countries of the world the morbidity rate of BCC differs due to the main predisposing factor of BCC development – ultraviolet radiation. In Ukraine, according to National Cancer Registry, 15882 new cases of non-melanoma skin cancer were registered in 2019–2020. Standardized morbidity rate of this pathology increased by 2,6% compared to 2018. Basal cell cancer commonly recurs (according to different experts, the rate varies from 10% to 80%), at the same time, distant metastases are diagnosed quite rarely. Understanding contribution of Hedgehog (Hh) signaling pathway to carcinogenesis of BCC has become a serious achievement in molecular biology. In spite of relatively benign course of BCC and variety of treatment methods of this disease, there is a high risk of recurrence, and in some patients, lesions may progress to such extent that they become unsuitable for local therapy which makes it urgent to search for alternatives to surgery and radiation therapy. Purpose – to study the peculiarities of course, treatment, development of complications of recurrent, locally advanced, metastatic inoperable BCC by the example of clinical cases. Materials and methods. Clinical observation of female patient K., 73 years old, who was undergoing treatment in the Department of Clinical Oncology and Hematology by reason of multiple BCC lesions (observation time 14 years) and female patient D., 42 years old, who was undergoing treatment in the Department of Radiation Pathology and Palliative Care by reason of aggressive course of locally advanced form of basalioma (observation time 29 years). Observation and treatment were performed in the State Organization «Grigoriev Institute for Medical Radiology and Oncology of the National Academy of Medical Sciences of Ukraine». Results. The clinical cases of observation and different stages of treatment of patients with constantly recurring aggressive BCC over a long period of time, 14 and 29 years, are demonstrated. Metastasing of BCC is confirmed in both cases, local advancement is shown, various methods of treatment were used: surgery, radiation therapy, cryodestruction, chemotherapy. Difficulty of patients' management is shown, especially when all available methods are used up. Treatment of complications of special therapy methods, multistage restoring plastic surgeries using different methods of plastic repair are described. Conclusions. Treating recurrent, metastatic, and locally advanced inoperable forms of BCC when one runs out of possibilities of the main treatment methods – surgery, radiation therapy, chemotherapy is a difficult task which requires further development of modern technology and treatment methods.

1 January 2021 in Eastern Ukrainian Medical Journal
Verified
Journal Article
Open access
PDF file
HKHalyna V. Kulinich
Halyna V. Kulinich
EPElvira B. Prohorova
Elvira B. Prohorova
Fedir HladkykhFedir Hladkykh
Fedir Hladkykh
Background. Radiation therapy (RT) is one of the main methods of treating cancer, including breast cancer (BC). This is one of the most knowledge-intensive medical industries, which is based on the latest advances in radiobiology, chemistry, radiation physics, engineering and others. Effective PT involves the use of fairly high doses of radiation, which is what determines the success of comprehensive treatment, in particular the increase in the number of patients who survived 5 years or more. In turn, the increase in survival after a course of combination treatment leads to an increase in the absolute number of patients with adverse treatment outcomes, including radiation-related complications (RC). The aim of the work was to characterize the changes in the skin electrical conductance in patients with breast cancer and an increased risk of RC. Materials and methods. The study was conducted on the basis of the clinic of the Grigoriev Institute of Medical Radiology and Oncology of NAMS of Ukraine. To study the skin electrical conductance, 16 patients with BC with an increased risk of RC were selected, with a mean age of 53.8 ± 3.7 (95% CI: 46.6–61.0) years. Studies of tissue electrical conductance were performed using the device "Electrodermatometer", measuring the indicators: modulus of complex impedance, impedance angle, complex impedance, and electrical capacity. Results and discussion. The study showed that in patients with BC and increased risk of RC, there was a decrease in the complex impedance of tissues at the study points during RT. The modulus of complex impedance at the mitral area decreased by only 6.8% (p > 0.05), while at the aortic, pulmonic and tricuspid areas, this figure was significantly (p < 0.05) decreased by 27.0%; 26.2% and 33.0%, respectively, relative to the initial indicators for RT. It was found that the most pronounced changes in the skin electrical conductance in patients with BC at risk of RC were observed at the projection points of the tricuspid and pulmonic areas, where these indicators were significantly (p < 0.05) increased by 41.1% and 34.2% relative to the baseline and equaled 9.8 ± 0.89 pF and 9.8 ± 0.88 pF, respectively. Conclusions. In patients with breast cancer at risk of RC, there was a statistically significant decrease (p < 0.05) in the value of the modulus of complex impedance by an average of 23.3% and a statistically significant increase (p < 0.05) in the tissue electrical conductance by an average of 29.8% relative to the baseline during radiation therapy.